Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Patients with diabetes mellitus are at increased risk of developing coronary artery disease (CAD) and have an increased incidence of recurrent events following revascularization. Choosing the most appropriate strategy to revascularize these high-risk patients is crucial for improving the clinical outcomes. Several studies, randomized trials and meta-analyses have compared short- and long-term outcomes following coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in diabetic patients suffering from CAD. The aim of this article is to review the currently available evidence on the role of PCI and CABG in the management of diabetic patients with CAD.

Original publication




Journal article


Hellenic J Cardiol

Publication Date





178 - 189


CABG, Diabetic patients, PCI, Revascularization, Angioplasty, Balloon, Coronary, Cardiac Surgical Procedures, Coronary Artery Bypass, Coronary Artery Disease, Diabetes Complications, Diabetes Mellitus, Female, Humans, Incidence, Male, Meta-Analysis as Topic, Myocardial Ischemia, Myocardial Revascularization, Percutaneous Coronary Intervention, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome